All 10 Sexual Health & STI Diagnostic Packages
Carefully structured profiles tailored for specific exposures, timeline milestones, and clinical symptoms. Confidential doorstep collection across Bengaluru.
Possible HIV Exposure Within the Last 72 Hours?
Post-Exposure Prophylaxis (PEP) is a short course of antiretroviral drugs that can stop HIV infection after exposure. PEP is most effective when started within 24 hours, and must be initiated within 72 hours. Do not wait for test results before seeking a physician consultation.
Explore Our Diagnostic Profiles
HIV-1 & HIV-2 Antigen & Antibody Screening (4th Gen Duo)
High-sensitivity 4th generation ECLIA detecting HIV-1 p24 antigen and HIV-1/2 antibodies simultaneously.
Clinical Indication: Individuals seeking confidential HIV screening following a potential exposure (optimal window 18–45 days), pre-marital evaluation, or routine health checkup.
Strictly confidential. Password-protected digital report delivery.
4th Generation HIV ECLIA/CLIA Confirmatory Screen
Chemiluminescent/electrochemiluminescent microparticle assay for early antigen-antibody resolution.
Clinical Indication: Patients wanting the earliest possible serological detection (18–45 days post-exposure) without waiting for standard 90-day antibody seroconversion.
Strictly confidential. Password-protected digital report delivery.
Syphilis Screening & Confirmation Profile (RPR + TPHA Reflex)
Dual serological approach: Non-treponemal quantitative RPR titer paired with treponemal TPHA confirmation.
Clinical Indication: Individuals with genital lesions, unexplained skin rashes on palms/soles, sexual partners of syphilis patients, or routine antenatal/STI screening.
Strictly confidential. Password-protected digital report delivery.
Chlamydia & Gonorrhea Real-Time PCR (Urine / Swab NAAT)
Gold-standard nucleic acid amplification test (NAAT) detecting C. trachomatis and N. gonorrhoeae DNA.
Clinical Indication: Patients with dysuria (painful urination), urethral or vaginal discharge, pelvic discomfort, or asymptomatic screening after unprotected sex.
Strictly confidential. Password-protected digital report delivery.
Triple STI Multiplex PCR Screen (Chlamydia, Gonorrhea, Trichomonas)
Simultaneous molecular detection of three common curable bacterial and protozoan sexually transmitted pathogens.
Clinical Indication: Individuals with persistent urethral discharge, vaginitis, pelvic fullness, or couples planning unbarriered intimacy.
Strictly confidential. Password-protected digital report delivery.
Essential Blood-Borne STI Screening Panel
Core serological panel covering major blood-borne and systemic sexually transmitted infections.
Clinical Indication: Patients requesting a dependable baseline blood screening after an exposure or as part of a pre-marital/routine wellness check.
Strictly confidential. Password-protected digital report delivery.
Comprehensive STI Master Diagnostic Panel (Blood + Urine 10-Target)
Our most exhaustive sexual health evaluation combining molecular PCR for localized infections with advanced serology.
Clinical Indication: Individuals with multi-symptom presentations, multiple exposures, or those seeking 360-degree sexual wellness assurance.
Strictly confidential. Password-protected digital report delivery.
Vaginal Infection Diagnostic Profile (Vaginitis & Microecology)
Comprehensive microscopy, culture, and molecular assessment for bacterial vaginosis, candidiasis, and trichomoniasis.
Clinical Indication: Women experiencing persistent, recurrent, or unusual vaginal discharge, odor, itching, or dyspareunia.
Strictly confidential. Password-protected digital report delivery.
Genital Herpes & Lesion Differential PCR (HSV-1, HSV-2, Syphilis)
Direct nucleic acid detection from lesion swabs for definitive identification of active herpes simplex virus.
Clinical Indication: Patients with active, painful blisters or ulcers in the genital, anal, or oral regions.
Strictly confidential. Password-protected digital report delivery.
Anatomical-Site Extragenital STI Screening (Pharyngeal & Rectal NAAT)
Targeted molecular swabs for extragenital gonorrhea and chlamydia infections following oral or anal exposure.
Clinical Indication: Individuals with pharyngitis after oral sex, rectal discharge/tenesmus, or comprehensive screening following multi-site sexual exposures.
Strictly confidential. Password-protected digital report delivery.
